Shattuck Labs, Inc. (STTK) SEC filings

STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30

$4.81−0.24 (-4.75%)

Close on Nov 12, 2026Market cap $482.75MP/E –Yield –

SEC filings

40 of Shattuck Labs's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Aug 11, 2026	Aug 11, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 11, 2026	SEC EDGAR
Current report	8-K	Jun 9, 2026	Jun 11, 2026	SEC EDGAR
Current report	8-K	Jun 8, 2026	Jun 9, 2026	SEC EDGAR
Current report	8-K	May 28, 2026	Jun 2, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 7, 2026	SEC EDGAR
Current report	8-K	May 7, 2026	May 7, 2026	SEC EDGAR
Proxy statement	DEF 14A	May 28, 2026	Apr 8, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 5, 2026	SEC EDGAR
Current report	8-K	Mar 5, 2026	Mar 5, 2026	SEC EDGAR
Current report	8-K	Feb 5, 2026	Feb 5, 2026	SEC EDGAR
Current report	8-K	Jan 22, 2026	Jan 22, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Nov 6, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Aug 25, 2025	Aug 26, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 14, 2025	SEC EDGAR
Current report	8-K	Aug 14, 2025	Aug 14, 2025	SEC EDGAR
Current report	8-K	Aug 4, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Jul 10, 2025	Jul 15, 2025	SEC EDGAR
Proxy statement	DEF 14A	Jul 10, 2025	May 21, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 1, 2025	SEC EDGAR
Current report	8-K	May 1, 2025	May 1, 2025	SEC EDGAR
Annual report, amended	10-K/A	Dec 31, 2024	May 1, 2025	SEC EDGAR
Annual report, amended	10-K/A	Dec 31, 2024	Apr 30, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 27, 2025	SEC EDGAR
Current report	8-K	Mar 27, 2025	Mar 27, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 14, 2024	SEC EDGAR
Current report	8-K	Nov 14, 2024	Nov 14, 2024	SEC EDGAR
Current report	8-K	Sep 30, 2024	Oct 1, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 1, 2024	SEC EDGAR
Current report	8-K	Aug 1, 2024	Aug 1, 2024	SEC EDGAR
Current report	8-K	Jun 14, 2024	Jun 14, 2024	SEC EDGAR
Current report	8-K	Jun 7, 2024	Jun 10, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 2, 2024	SEC EDGAR
Current report	8-K	May 2, 2024	May 2, 2024	SEC EDGAR
Proxy statement	DEF 14A	Jun 7, 2024	Apr 23, 2024	SEC EDGAR
Current report	8-K	Mar 1, 2024	Mar 4, 2024	SEC EDGAR
Annual report	10-K	Dec 31, 2023	Feb 29, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Shattuck Labs's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is STTK.

Compare: STTK vs IBIO · STTK vs YARW · STTK vs DNTH · STTK vs RNAC · STTK vs MCRB

Revenue growth-100.0% · median 115.0%

Company	Revenue	Growth
MCRB	$2.13M	+505.4%
IBIO	$1.08M	+115.0%
RNAC	$1.03M	–
YARW	$476.00K	-2.1%
STTK	$0	-100.0%
DNTH	–	–

Company

Next earnings (est.): Mar 4, 2027, before open
Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 40
Held by institutions: 83.5%
Auditor: KPMG LLP
SEC CIK: 1680367

Advertisement
300 × 250

See a number that looks wrong?